Pharmaceutical Product Development Balance Sheet
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Assets | Dec 07 | Dec 06 | Dec 05 |
|---|---|---|---|
| Current Assets | |||
| Cash | 502.4 | 435.7 | 319.8 |
| Net Receivables | 521.0 | 436.0 | 328.4 |
| Inventories | -- | -- | -- |
| Other Current Assets | 49.8 | 36.5 | 34.7 |
| Total Current Assets | 1,073.2 | 908.2 | 682.9 |
| Net Fixed Assets | 356.2 | 323.5 | 210.0 |
| Other Noncurrent Assets | 255.0 | 249.8 | 258.2 |
| Total Assets | 1,684.4 | 1,481.6 | 1,151.2 |
| Liabilities and Shareholder's Equity | Dec 07 | Dec 06 | Dec 05 |
| Current Liabilities | |||
| Accounts Payable | 267.5 | 224.6 | 353.6 |
| Short-Term Debt | -- | 75.2 | 1.6 |
| Other Current Liabilities | 205.8 | 195.7 | -- |
| Total Current Liabilities | 473.2 | 495.5 | 355.3 |
| Long-Term Debt | -- | -- | 22.7 |
| Other Noncurrent Liabilities | 61.0 | 33.2 | 31.0 |
| Total Liabilities | 534.3 | 528.7 | 408.9 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 1,150.1 | 952.9 | 742.2 |
| Total Equity | 1,150.1 | 952.9 | 742.2 |
| Shares Outstanding (mil.) | 119.1 | 117.6 | 116.0 |
This data is provided as per license from EDGAR Online
